All Pharma News
Dermavant`s VTAMA® sNDA Accepted for Atopic Dermatitis in ?2 Years

Dermavant`s VTAMA® sNDA Accepted for Atopic Dermatitis in ?2 Years
BUSINESSWIRE
29 Apr 2024
Share Share
Dermavant Submits sNDA for VTAMA Cream for the Treatment of Atopic Dermatitis

Dermavant Submits sNDA for VTAMA Cream for the Treatment of Atopic Dermatitis
BUSINESSWIRE
14 Feb 2024
Share Share
Dermavant Announces Positive Data from Phase 3 in Atopic Dermatitis with VTAMA®

Dermavant Announces Positive Data from Phase 3 in Atopic Dermatitis with VTAMA®
BUSINESSWIRE
11 Jan 2024
Share Share
Dermavant`s Vtama excels in another trial in atopic dermatitis

Dermavant`s Vtama excels in another trial in atopic dermatitis
Kevin Dunleavy FIERCE PHARMA
11 Jan 2024
Share Share
Dermavant Announces Positive Results from Phase 4 Open-Label Trial of VTAMA

Dermavant Announces Positive Results from Phase 4 Open-Label Trial of VTAMA
BUSINESSWIRE
06 Dec 2023
Share Share
Dermavant CEO draws Botox comparison to instill Vtama confidence

Dermavant CEO draws Botox comparison to instill Vtama confidence
Kevin Dunleavy FIERCE PHARMA
28 Nov 2023
Share Share
With Dermavant`s Vtama struggling, Leerink slashes projections

With Dermavant`s Vtama struggling, Leerink slashes projections
Kevin Dunleavy FIERCE PHARMA
14 Nov 2023
Share Share
Dermavant Presents Positive Results from Phase 4 Open-Label Trial of VTAMA

Dermavant Presents Positive Results from Phase 4 Open-Label Trial of VTAMA
BUSINESSWIRE
20 Oct 2023
Share Share
Dermavant to Present New Positive Data from Phase 4 of VTAMA

Dermavant to Present New Positive Data from Phase 4 of VTAMA
BUSINESSWIRE
16 Oct 2023
Share Share
Dermavant Champions a Culture that Earns Three Best Workplace Rankings in 2023

Dermavant Champions a Culture that Earns Three Best Workplace Rankings in 2023
BUSINESSWIRE
13 Oct 2023
Share Share